Triple Infection & Epcoritamab: Case Report
BOSTON, February 10, 2026 — A lymphoma patient undergoing treatment with epcoritamab simultaneously contracted three infections – Campylobacter coli, cytomegalovirus (CMV), and SARS-CoV-2 – highlighting the … Read more